NCT02402023View on ClinicalTrials.gov

Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Contingency Management (CM)

CM is standard care plus monetary payment delivered contingent on abstinence.

BEHAVIORAL

Standard of Care (SC)

Standard of care consists of smoking cessation counseling sessions and nicotine patches.

Trial Locations (2)

06510

Yale Cancer Center, New Haven

29425-8350

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT02402023 - Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery | Biotech Hunter | Biotech Hunter